Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCastelnau Group Regulatory News (CGL)

Share Price Information for Castelnau Group (CGL)

Share Price is delayed by 15 minutes
Get Live Data
89.50    0.00 (0.00%)
Bid:
88.00
Ask:
91.00
Spread: 3.00 (3.409%)
Market Cap: £298.49m
CGL Live PriceLast checked at - London Stock Exchange

Intraday Castelnau Group Share Chart

Dealing Disclosure-XL Group Plc Amendment

11 Mar 2015 07:00

RNS Number : 0945H
JPMorgan Securities Plc
10 March 2015
Β 

ο»Ώ

AMENDMENT

INCREASED EQUITY PURCHASES BY 10,400 TO 10,550.

Β 

Β 

FORM 8.5 (EPT/RI)

Β 

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

J.P. Morgan Securities plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

XL Group Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Catlin Group Ltd

(d) Date dealing undertaken:

03 March 2015

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

Catlin Group Ltd

Β 

Β 

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

(USD)

Lowest price per unit paid/received

(USD)

Ordinary Shares

Purchases

Β 

Sales

10,550

Β 

10,550

36.1900

Β 

36.1841

36.1841

Β 

36.1841

Β 

(b) Derivatives transactions (other than options)

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(USD)

Β 

Β 

Β 

Β 

Β 

(c) Options transactions in respect of existing securities

Β 

(i) Writing, selling, purchasing or varying

Β 

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

(EUR)

Type

e.g. American, European etc.

Expiry date

Β 

Option money paid/ received per unit

(EUR)

Β 

Β 

Β 

Β 

Β 

Β 

(ii) Exercising

Β 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

(USD)

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

None

Β 

Β 

Β 

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

Β 

Β 

Β 

Date of disclosure:

10 March 2015

Contact name:

Jasper Niesing

Β 

Telephone number:

020 7742 4613

Β 

Catlin is a Bermudian entity and is therefore not subject to the City Code. Shareholders of Catlin and others dealing are therefore not obliged to disclose any of their dealings under the provisions of the City Code. However, market participants are requested to make disclosures as if the City Code applied and as if Catlin were in an "offer period".

Β 

Accordingly, public disclosures consistent with the provisions of Rule 8 of the City Code should be released directly through a Regulatory Information Service and should not be emailed to the Takeover Panel.

Β 

The City Code can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCKMGMFRGGGKZM
Date   Source Headline
6th Mar 20142:35 pmRNSHolding(s) in Company
3rd Mar 20143:11 pmRNSTotal Voting Rights
21st Feb 201411:25 amRNSPurchase by EBT
19th Feb 20145:02 pmRNSPurchase by EBT
17th Feb 20144:03 pmRNSPurchase by EBT
13th Feb 20142:37 pmRNSHolding(s) in Company
12th Feb 20146:00 pmRNSPurchase by EBT
12th Feb 201412:12 pmRNSDirector/PDMR Shareholding
11th Feb 20146:23 pmRNSPurchase by EBT
10th Feb 20149:00 amRNSDividend Declaration
10th Feb 20147:00 amRNSFinal Results
6th Feb 20149:55 amRNSHolding(s) in Company
3rd Feb 201412:38 pmRNSTotal Voting Rights
7th Jan 20147:00 amRNSSingapore Branch
3rd Jan 20145:00 pmRNSTotal Voting Rights
2nd Jan 20145:04 pmRNSBlocklisting Interim Review
2nd Jan 20143:44 pmRNSDirector/PDMR Shareholding
23rd Dec 201311:58 amRNSDirector/PDMR Shareholding
25th Nov 20139:00 amRNSFinancial Calendar
19th Nov 20133:42 pmRNSDirector/PDMR Shareholding
11th Nov 20137:00 amRNSInterim Management Statement
1st Nov 201311:45 amRNSTotal Voting Rights
31st Oct 20138:27 amRNSInvestor Day
29th Oct 201311:40 amRNSAdditional Listing
1st Oct 20135:13 pmRNSTotal Voting Rights
27th Sep 20134:22 pmRNSDirector/PDMR Shareholding
24th Sep 20135:40 pmRNSDirector/PDMR Shareholding
2nd Sep 201311:28 amRNSTotal Voting Rights
15th Aug 20134:31 pmRNSDirector/PDMR Shareholding
9th Aug 20139:00 amRNSDividend Declaration
9th Aug 20137:00 amRNSHalf Yearly Report
1st Aug 201311:35 amRNSTotal Voting Rights
1st Jul 201312:35 pmRNSBlocklisting Interim Review
1st Jul 201312:31 pmRNSTotal Voting Rights
19th Jun 20133:15 pmRNSDirector/PDMR Shareholding
14th Jun 20135:06 pmRNSDirector/PDMR Shareholding
6th Jun 201310:28 amRNSDirector/PDMR Shareholding
3rd Jun 201312:55 pmRNSTotal Voting Rights
28th May 201312:20 pmRNSDirector/PDMR Shareholding
22nd May 20133:35 pmRNSDirector/PDMR Shareholding
10th May 20137:00 amRNSResult of AGM
10th May 20137:00 amRNSInterim Management Statement
1st May 20139:39 amRNSTotal Voting Rights
24th Apr 20136:10 pmRNSDirector/PDMR Shareholding
17th Apr 20133:45 pmRNSDisclosure of New Directorship
9th Apr 20134:48 pmRNSDirector/PDMR Shareholding
5th Apr 20135:12 pmRNSNotice of AGM
2nd Apr 20132:12 pmRNSTotal Voting Rights
28th Mar 20132:09 pmRNSDirector/PDMR Shareholding
28th Mar 20139:47 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.